By Tom Fish ( November 14, 2022, 1:33 PM GMT) -- London-listed Indivior PLC said on Monday that it is offering to buy Opiant Pharmaceuticals Inc., a U.S. company that develops treatments to combat addiction, in a $145 million all-cash deal that offers potential for a performance-linked sweetener....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.